Timothy C. Wentworth - 28 Aug 2025 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Aug 2025, 15:22:06 UTC
Prior SEC filing
05 Nov 2024
Next SEC filing
11 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Timothy C. Wentworth by Cherita Thomas, Attorney-in-Fact

Key filing fact

Timothy C. Wentworth filed Form 4 for Walgreens Boots Alliance, Inc. (WBA) on 28 Aug 2025.

Key facts

  • This page summarizes Timothy C. Wentworth's Form 4 filing for Walgreens Boots Alliance, Inc. (WBA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Aug 2025, 15:22.

Change

  • Previous filing in this sequence was filed on 05 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001252016 Primary reporting owner

WENTWORTH TIMOTHY C

Relationship
Chief Executive Officer
Address
C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD
Signature
/s/ Timothy C. Wentworth by Cherita Thomas, Attorney-in-Fact
Signature date
28 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WBA transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-1,332,014
Change %
-100%
Price
Shares after
0
Date
28 Aug 2025
Ownership
Direct
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Timothy C. Wentworth is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Includes shares underlying restricted stock units ("RSUs"), inclusive of RSUs issued in lieu of dividends.

Footnote F2

Pursuant to the Agreement and Plan of Merger, dated as of March 6, 2025 (the "Merger Agreement"), by and among Walgreens Boots Alliance, Inc., a Delaware corporation (the "Company"), Blazing Star Parent, LLC, a Delaware limited liability company ("Parent"), Blazing Star Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), and the other affiliates of Parent named therein, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent.

Footnote F3

At the effective time of the Merger (the "Effective Time") each share of Common Stock was automatically converted into the right to receive from Parent (i) $11.45 in cash, without interest thereon and subject to all applicable withholding (the "Per Share Cash Consideration"), and (ii) one divested asset proceed right issued by Parent or one of its affiliates subject to and in accordance with the divested asset proceed rights agreement (each, a "Divested Asset Proceed Right" and, collectively with the Per Share Cash Consideration, the "Per Share Consideration").

Footnote F4

Pursuant to the Merger Agreement, each RSU owned by the reporting person at the Effective Time was cancelled in exchange for the Per Share Consideration, provided that, payment of such consideration with respect to any RSUs that were unvested as of the Effective Time will remain subject to the Reporting Person's continued service as an employee, consistent with the vesting conditions applicable to such RSU immediately prior to the Effective Time.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .